NCT07492628
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
Clinical trial condition
Metastatic Urothelial Carcinoma
Explore clinical trials studying Metastatic Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.
55 public trials
19 recruiting studies
Metastatic Urothelial Carcinoma trial results
NCT07221942
- Conditions
- Advanced Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +5 more
- Locations
-
- Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
NCT04623502
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +29 more
- Locations
-
- University of Texas Southwestern Medical Center Dallas, Texas, United States
Recruiting
Criteria for Selecting First-line Metastatic Treatment for Patients With Urothelial Carcinoma
NCT07339878
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Metastatic Urothelial Carcinoma, +3 more
- Locations
-
- Service Oncologie Médicale - CHU de Strasbourg - France Strasbourg, France
NCT04724018
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT05107674
- Conditions
- Adenoma, Adnexal Diseases, Breast Diseases, +75 more
- Locations
-
- City of Hope Duarte, California, United States
- University of Southern California Los Angeles, California, United States
- University of California, San Francisco San Francisco, California, United States
- University of Colorado School of Medicine Aurora, Colorado, United States
NCT06493552
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Metastatic Urothelial Carcinoma, +4 more
- Locations
-
- Sarcoma Oncology Center Santa Monica, California, United States
NCT04641936
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Metastatic Urothelial Carcinoma, +3 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
NCT05733000
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +67 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
Not yet recruiting
N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer
NCT07217496
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States